Martínez, Carmen http://orcid.org/0000-0002-8401-7306
de Haro, Manuel Espeso
Romero, Samuel
Gutiérrez, Antonio
Domingo-Domènech, Eva
González-Rodríguez, Ana P.
Zeberio, Izaskun
Martínez-Badas, María Paz
Rodríguez-Izquierdo, Antonia
Carpio, Cecilia
Bastos-Oreiro, Mariana
Hernández-Rivas, José Ángel
Vallansot, Rolando
Kelleher, Nicholas
Díaz-Gálvez, Francisco J.
Torrado, Tamara
Pereira, Arturo
García-Sanz, Ramón
,
Article History
Received: 17 May 2022
Accepted: 12 October 2022
First Online: 12 November 2022
Declarations
:
: C.M. declares consultancy for and honoraria from Takeda and Bristol Myers Squibb; M.E.H. declares honoraria from Takeda, Roche, Janssen, Kite/Gilead, Amgen, Pfizer, EusaPharma, and Servier; S.R. declares honoraria from Takeda; E.D.D. has received honoraria from Takeda and Bristol Myers Squibb; A.P.G.R. declares consultancy for and honoraria from Takeda; I.Z. declares consultancy for and honoraria from Takeda; M.P.M.B. declares honoraria from Takeda; A.R.I. declares honoraria from Takeda; C.C. declares honoraria and/or non-financial support from Takeda, Regeneron, Novartis, and Bristol Myers Squibb; J.A.H.R. declares consultancy for and speaker’s bureau from Takeda; R.G.S. declares research support by the Spanish National Healthy System, Regional Healthy System (<i>Castilla y León</i>), <i>Asociación Española Contra el Cancer</i> (AECC), Takeda, Gilead, Astellas, honoraria from Amgen, Millennium/Takeda, Janssen, Incyte, Astellas, BeiGene, Astra Zeneca, Pfizer, and Speakers Bureau/Scientific Advisory Board for Amgen, Pharmacyclics, Millennium/Takeda. F.J.D.G., M.B., R.V., N.K., and T.T. declare no conflict of interest.